Lord, Abbett & Co. LLC Regeneron Pharmaceuticals, Inc. Transaction History

Lord, Abbett & Co. LLC

$31.4 Billion
Q3 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 64,081 shares of REGN stock, worth $45 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

64,081

Previous 64,081 -0.0%

Holding current value

$45 Million

Previous $67.4 Million -0.0%

% of portfolio

0.21%

Previous 0.22%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $22.7 Million - $26.6 Million	-22,151 Reduced 25.69%	64,081 $67.4 Million
Q2 2024 Oct 07, 2024	BUY	$883.2 - $1071.19 $35.3 Million - $42.8 Million	39,950 Added 86.32%	86,232 $90.6 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $35.3 Million - $42.8 Million	39,950 Added 86.32%	86,232 $90.6 Million
Q1 2024 Oct 07, 2024	SELL	$902.69 - $993.35 $36.1 Million - $39.7 Million	-39,950 Reduced 46.33%	46,282 $44.5 Million
Q1 2024 May 09, 2024	BUY	$902.69 - $993.35 $41.8 Million - $46 Million	46,282 New	46,282 $44.5 Million
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $42.7 Million - $51.6 Million	-78,377 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $16.3 Million - $21.2 Million	32,960 Added 72.57%	78,377 $48.9 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $15.3 Million - $22.5 Million	45,417 New	45,417 $22.2 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $10.8 Million - $15 Million	-36,117 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $13.4 Million - $15.9 Million	36,117 New	36,117 $14.8 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $15.9 Million - $20.8 Million	-44,268 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$431.38 - $504.0 $26.5 Million - $31 Million	-61,468 Reduced 58.13%	44,268 $19.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	105,736	105,736 $51.9 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account

Lord, Abbett & Co. LLC Regeneron Pharmaceuticals, Inc. Transaction History